Answers are grounded in this paper and cite their sources.
Acute myeloid leukaemia, epigenetic, 2-hydroxyglutarate (2-HG), isocitrate dehydrogenase 1 (IDH1), olutasidenib, targeted therapies
No takes yet. Share an insight, caveat, or question.
Pasquier et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: